6 ASX 200 shares with fresh buy ratings this week

Brokers retain a positive view on Resmed, Newmont, Qantas and other ASX 200 shares. 

S&P/ASX 200 Index (ASX: XJO) shares recovered early losses to close just inside the green after interest rates were kept on hold yesterday.

ASX 200 shares had been sharply lower in early trading but moved up immediately after the rates announcement at 2.30pm.

The ASX 200 closed 0.042% higher at 8,917.7 points.

Meanwhile, brokers indicated continuing confidence in several ASX 200 shares by renewing their buy recommendations.

Let's take a look.

Red buy button on an Apple keyboard with a finger on it.

Image source: Getty Images

Resmed CDI (ASX: RMD)

The Resmed share price closed 1.3% lower at $27.39 on Tuesday.

Over the past six months, this ASX 200 healthcare share has fallen 28%.

Citi renewed its buy rating on Resmed shares this week.

The broker cut its 12-month price target substantially from $48 to $38.

This still suggests a potential near-40% upside ahead.

NextDC Ltd (ASX: NXT)

The NextDC share price closed 0.4% higher at $14.87 on Tuesday.

This ASX 200 tech share has risen 21% in the calendar year to date (YTD) amid a broader sector rebound.

Citi reiterated its buy rating on NextDC shares on Monday with a price target of $19.10.

This implies potential capital gains of almost 30% ahead.

Mineral Resources Ltd (ASX: MIN)

The Mineral Resources share price finished at $70.79, down 0.9%, yesterday.

Over the past six months, this ASX 200 mining share has soared 40%.

Bell Potter reaffirmed its buy rating on Mineral Resources shares on Monday.

The broker lifted its 12-month target from $80.50 to $83.

This suggests a potential 17% upside ahead.

Newmont Corporation CDI (ASX: NEM)

The Newmont share price finished at $150.16 on Tuesday, up 2%.

This ASX 200 gold share has been volatile in 2026, and is down 0.6% YTD.

Macquarie renewed its buy rating on Newmont shares on Tuesday.

The broker lowered its 12-month target from $192 to $176.

This implies potential capital growth of 17% over the next year.

Qantas Airways Ltd (ASX: QAN)

The Qantas share price finished yesterday's trading session at $9.96, up 0.2%.

The ASX 200 airline share has ripped 18% over the past month.

UBS renewed its buy rating on Qantas with a $11.15 share price target.

This suggests a potential 12% upside ahead.

Goodman Group (ASX: GMG)

The Goodman share price closed at $32.26 on Tuesday, up 0.6%.

This ASX 200 real estate share has popped 7% higher over this past month of trading.

Bell Potter reiterated its buy rating on Goodman shares on Monday with a price target of $35.50.

This implies a potential 10% upside ahead.

Goodman announced a dividend of 15 cents per share for 2H FY26 on Tuesday.

The ex-dividend date is 29 June. Investors will receive their dividend on 26 August.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Happy teen friends jumping in front of a wall.
Broker Notes

4 ASX shares tipped by brokers to return 63% to 125%

There is plenty of potential for growth ahead for these ASX shares.

Read more »

Three exuberant runners dash towards the camera. One raises her arms in triumph; another jumps in the air with arms raised. The third runner gives a satisfied smile.
Broker Notes

South32, Cochlear, Westpac shares: Buy, hold, or sell?

One of these ASX shares is tipped to fall around 10%.

Read more »

A mining worker clenches his fists celebrating success at sunset in the mine.
Broker Notes

Macquarie says this ASX uranium producer has more than 15% upside

A new mine design has impressed the broker.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Buy, hold, sell: Netwealth, Tabcorp, Healius shares

Let's check out some new ratings on ASX shares today.

Read more »

Doctor with stethoscope using a tablet in a hospital.
Broker Notes

What is this broker's view on Telix shares after yesterday's crash?

Here is the latest outlook from Bell Potter.

Read more »

Two happy and excited friends in euphoria holding a smartphone, after winning in a bet.
Broker Notes

Why this ASX 200 share could rise 80%

Bell Potter believes this share could deliver big returns over the next 12 months.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

Morgans tips both of these ASX shares to rise 31%

Strong macro themes back a rise for both of these companies.

Read more »

Australian dollar notes and coins in a till.
Broker Notes

Should I buy Coles shares for passive income?

A leading expert provides his forecast for Coles outperforming shares.

Read more »